By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IntelliCell BioSciences today announced an exclusive agreement to sell and distribute EMD Millipore's Guava flow cytometry platform for stromal vascular fraction (SVF) applications.

IntelliCell manufactures SVF containing stem cells derived from fatty tissue. The deal streamlines the development of IntelliCell's tissue processing centers in the US, the New York-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.